Drug Shortage Report for INDIUM DTPA IN 111
| Report ID | 186110 |
| Drug Identification Number | 02329093 |
| Brand name | INDIUM DTPA IN 111 |
| Common or Proper name | Pentetate Indium Disodium In 111 Injection |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PENTETATE INDIUM DISODIUM IN 111 |
| Strength(s) | 37MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRATHECAL INTRATHECAL |
| Packaging size | 1.5 mL |
| ATC code | V09AX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-03-03 |
| Estimated end date | 2023-03-17 |
| Actual end date | 2023-03-17 |
| Shortage status | Resolved |
| Updated date | 2023-03-18 |
| Company comments | Manufacturing issues |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-18 | English | Compare |
| v7 | 2023-03-17 | French | Compare |
| v6 | 2023-03-17 | English | Compare |
| v5 | 2023-03-08 | French | Compare |
| v4 | 2023-03-08 | English | Compare |
| v3 | 2023-03-04 | English | Compare |
| v2 | 2023-03-03 | French | Compare |
| v1 | 2023-03-03 | English | Compare |
Showing 1 to 8 of 8